Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA062399-03
Application #
2103604
Study Section
Special Emphasis Panel (SRC (68))
Project Start
1994-03-25
Project End
1997-12-31
Budget Start
1996-01-01
Budget End
1996-12-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Neurosurgery
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Taylor, Jennie W; Parikh, Mili; Phillips, Joanna J et al. (2018) Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma. J Neurooncol 140:477-483
Nghiemphu, Phioanh Leia; Ebiana, Victoria Asuquo; Wen, Patrick et al. (2018) Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02. J Neurooncol 136:79-86
Shonka, Nicole; Piao, Yuji; Gilbert, Mark et al. (2013) Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept. Target Oncol 8:117-25
Nayak, Lakshmi; Abrey, Lauren E; Drappatz, Jan et al. (2013) Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma. Leuk Lymphoma 54:58-61
Vivanco, Igor; Robins, H Ian; Rohle, Daniel et al. (2012) Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov 2:458-71
Lee, Eudocia Q; Kuhn, John; Lamborn, Kathleen R et al. (2012) Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02. Neuro Oncol 14:1511-8
Lee, Eudocia Q; Puduvalli, Vinay K; Reid, Joel M et al. (2012) Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03. Clin Cancer Res 18:6032-9
de Groot, John F; Piao, Yuji; Tran, Hai et al. (2011) Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept. Clin Cancer Res 17:4872-81
Iwamoto, Fabio M; Lamborn, Kathleen R; Kuhn, John G et al. (2011) A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03. Neuro Oncol 13:509-16
Nghiemphu, Phioanh Leia; Wen, Patrick Y; Lamborn, Kathleen R et al. (2011) A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys 81:1422-7

Showing the most recent 10 out of 52 publications